One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study.
Till UhligLars F KaroliussenJoe SextonTore K KvienEspen A HaavardsholmFernando Perez-RuizHilde Berner HammerPublished in: Arthritis research & therapy (2022)
ACTRN12618001372279.